A CLINICAL STUDY TO EVALUATE THE EFFICACY OF COMBINED EFFECT OF AYURVEDIC DRUGS AND BASTI IN THE MANAGEMENT OF CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME VIS-À-VIS PAKWASHAYAGATAVATA
DOI:
https://doi.org/10.70066/jahm.v4i1.288Keywords:
Pakwashayagatavata, irritable bowel syndrome, bastiAbstract
Constipation predominant Irritable bowel syndrome (IBS-c) can be interrelated with pakwashayagatavata. IBS-c is a gut
motility disorder associated with abdominal pain, constipation and bloated ness. A total of 25 patients suggestive of
feature of pakwashayagatavata or constipation predominant irritable bowel syndrome were enrolled and were randomly
divided into two groups. In Group A, 15 patients were enrolled and were given Panchasakarchoorna and
Mahashankhavati. In Group B, 10 patients were enrolled and were given combination of Ayurvedic drugs
(Panchasakarchoorna,Mahashankhavati) along with basti(~medicated enema)for a period of 16 days.Total duration of
study was of 1 month. Both the groups had shown significant improvement in chronic constipation, bloating
etc.(p<0.01),butgroup Bshowed better improvement in comparison to group A. Thus, basti(~medicated enema) therapy is
effective in the management of pakwashayagatavata or constipation predominant IBS.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 PRAGYA SINGHAL

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.